Search Results
Jun 15, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.62 Million Tokens, and Total Crypto and Total Cash Holdings of $10.4 Billion
Bitmine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETH
More news about: Bitmine Immersion Technologies, Inc.
Jun 15, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.62 Million Tokens, and Total Crypto and Total Cash Holdings of $10.4 Billion
Bitmine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETHNORWALK,
More news about: Bitmine Immersion Technologies, Inc.
Jun 15, 2026, 08:25 ET Hybar Announces Proposed Offering of $400,000,000 of Senior Secured Green Notes
mini mill (the "Expansion Mini Mill"), (ii) to fund costs related to the offering of the Notes and other concurrent financing transactions, (iii) to refinance certain existing senior project facilities, and (iv) the remainder, if any, for general corporate purposes.The Notes will be fully
More news about: Hybar LLC
Jun 15, 2026, 08:24 ET ODNB Financial Corporation and National Capital Bancorp, Inc. Announce Merger of Equals Creating a Top Tier Community Bank Headquartered in Washington, D.C. with Approximately $2.4 Billion in Total Assets
accretion to reported earnings that may be realized from the proposed transaction; (ii) the expected timing of completion of the proposed transaction; and (iii) ODNB's and NACB's plans, objectives, expectations and intentions and other statements contained in this communication that are not historical facts.
More news about: ODNB Financial Corporation
Jun 15, 2026, 08:10 ET Harbour BioMed and BioMap Jointly Initiate MegaStream TechBio: A Leading Global Drug Development Platform Joins Forces with Premier Life Science Foundation Models to Set New Benchmarks for AI-Driven Complex Biologics R&D
generate over 5 petabytes of high-quality, AI-ready life science data within five years—continuously fueling rapid AI model evolution.III. Scale Up Next-Generation R&D Pipelines: End-to-End Loop from AI Creation to Clinical ValueHarbour BioMed and BioMap's first AI+ biotech-driven
More news about: Harbour BioMed
Jun 15, 2026, 07:00 ET HONEYWELL BOARD OF DIRECTORS APPROVES SPIN-OFF OF HONEYWELL AEROSPACE
conditions related thereto; (ii) the possibility that the spin-off transaction will not be completed within the anticipated time period or at all; (iii) the possibility that the spin-off transaction will not achieve its intended benefits; (iv) the impact of the spin-off transaction on Honeywell's businesses
More news about: Honeywell
Jun 15, 2026, 07:00 ET Il Gruppo Menarini presenta i dati dello studio di fase 3 SENTRY su selinexor più ruxolitinib nella mielofibrosi in occasione del Congresso 2026 dell'Associazione Europea di Ematologia (EHA)
SENTRY (NCT04562389), uno studio clinico pivotale di fase III, è uno studio randomizzato, in doppio cieco, controllato con placebo, che valuta l'efficacia di selinexor 60 mg in associazione con ruxolitinib nel trattamento
More news about: Menarini Industrie Farmaceutiche Riunite
Jun 15, 2026, 06:00 ET Powerfleet Reports Results for Fourth Quarter and Full-Year Fiscal 2026
and ongoing business transformation initiatives; (ii) significant losses, accumulated deficits and an inability to achieve or sustain profitability; (iii) future global economic, political and business conditions, including inflation, interest rate increases, foreign exchange instability, geopolitical
More news about: Powerfleet
Jun 15, 2026, 03:57 ET GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit with the Schall Law Firm
the Company made false and misleading statements to the market. Grail misled investors about the prospects of its NHS-Galleri trial in reducing Stage III-IV cancers, concealing adverse facts from the trial while describing it positively. The Company's optimism related to the NHS-Galleri study was overstated,
More news about: The Schall Law Firm
Jun 15, 2026, 02:52 ET Akeso's Next-Generation HER3 ADC AK138D1 Combined with Ivonescimab: First Patient Enrolled in Phase Ib/II Breast Cancer Study, Advancing the IO2.0 + ADC2.0 Strategy
TNBC.Early data from AK138D1 studies have already shown meaningful efficacy and a strong safety profile in breast cancer. Concurrently, a Phase III study of ivonescimab-based combination therapy in first-line TNBC is ongoing. The combination of AK138D1 and ivonescimab is poised to emerge as a highly
More news about: Akeso, Inc.
Jun 14, 2026, 20:15 ET CARsgen Presents Allogeneic CAR T-cell Products CT0596 and CT1190B at EHA 2026
level. All patients were heavily pretreated, with a median of 3.5 prior lines of therapy (range 2, 6). Most patients had advanced disease (ISS Stage III: n=5), 1 had extramedullary disease, and 5 patients had high-risk cytogenetics.All 8 patients reported treatment-emergent adverse events (TEAEs),
More news about: CARsgen Therapeutics
Jun 13, 2026, 23:00 ET Zillow Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Zillow Group, Inc. - ZG, Z
(ii) as a result of the Redfin Agreement, Zillow faced a materially heightened risk of regulatory scrutiny and liability under federal antitrust laws; (iii) upon the filing of an antitrust lawsuit, Zillow continued to downplay its legal exposure; and (iv) as a result, Defendants' statements about Zillow's
More news about: ClaimsFiler
Jun 12, 2026, 23:00 ET SES AI Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against SES AI Corporation - SES
no operational capacity; (ii) the company created the appearance of revenue by purchasing services tied to its own Molecular Universe transactions; (iii) despite its optimistic growth statements, SES AI faced significant logistics constraints in Q4 2025 that materially impacted revenue for that quarter;
More news about: ClaimsFiler
Jun 12, 2026, 22:00 ET ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA
that: (i) the Company engaged in an undisclosed related party transaction; (ii) the Company used channel stuffing to create an appearance of revenue; (iii) the Company lacked adequate internal controls; and (iv) as a result, Defendants' statements about the Company's business, operations, and prospects
More news about: ClaimsFiler
Jun 12, 2026, 22:00 ET Sportradar Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Sportradar Group AG - SRAD
Sportradar's operations; (ii) the Company's Know-Your-Customer ("KYC") and compliance processes were not as robust as Defendants' had claimed; and (iii) as a result, the Company's statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable
More news about: ClaimsFiler
Jun 12, 2026, 22:00 ET PicS Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against PicS N.V. - PICS
R$590 million of exposures from Stage 2 to Stage 3, resulting in an incremental ECL charge of R$88 million for the quarter ended December 31, 2025; (iii) the Company experienced an undisclosed Stage 3 formation rate exceeding 7% in the fourth quarter of 2025, materially departing from the historical trends
More news about: ClaimsFiler
Jun 12, 2026, 21:10 ET PICS INVESTOR NOTICE: PicS N.V. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
exposures previously classified as Stage 2 to Stage 3, leading to an incremental ECL charge of R$88 million in the three months ended December 31, 2025; (iii) PicS N.V. had experienced a heightened, but unreported, Stage 3 formation rate of more than 7% in the fourth quarter of 2025 that deviated substantially
More news about: Robbins Geller Rudman & Dowd LLP
Jun 12, 2026, 19:05 ET FSK INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that FS KKR Capital Corp. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
(ii) FS KKR overstated the valuation of its portfolio investments and/or overstated the effectiveness of FS KKR's portfolio valuation process; and (iii) FS KKR overstated the durability of its quarterly distribution strategy.The FS KKR class action lawsuit further alleges that
More news about: Robbins Geller Rudman & Dowd LLP
Jun 12, 2026, 16:38 ET J. Colby Williams to Succeed Jeffrey Welch as Executive Vice President and General Counsel at Red Rock Resorts
leadership and contributions that have positioned us for continued success, and to wish him the best in his well-deserved retirement," said Frank Fertitta III, Chief Executive Officer of the Company. "We are looking forward to welcoming Colby, a longtime and trusted advisor to the Company and to me. His successful
More news about: Red Rock Resorts, Inc.
Jun 12, 2026, 16:17 ET M3-Brigade Acquisition V Corp. Announces Cancellation of Extraordinary General Meeting of Shareholders to Approve Business Combination
to mutually terminate the Business Combination Agreement, dated as of July 7, 2025 (the "BCA") by and among (i) the Company, (ii) ReserveOne, (iii) ReserveOne Holdings, Inc., a wholly owned subsidiary of ReserveOne ("Pubco"), (iv) R1 SPAC Merger Sub, Inc., a wholly owned subsidiary of Pubco,
More news about: M3-Brigade Acquisition V Corp.
Jun 12, 2026, 16:15 ET Target Announces Voting Results from 2026 Annual Meeting of Shareholders
0.9John R. Hoke III98.8
More news about: Target Corporation
Jun 12, 2026, 14:56 ET What Stories Are Shaping Your Life?
artists, and collaborators for conversations that challenge perspectives and deepen connections. Past Spark Salon speakers have included illusionist Harris III, psychologist Scott Barry Kaufman, PhD, nutrition therapist Kim Shapira, MS, RD, mythologist John Bucher, Harvard Business School professor and author
More news about: Unlikely Collaborators
Jun 12, 2026, 12:50 ET PICS CLASS ACTION ALERT: Johnson Fistel Encourages PicS N.V. Shareholders to Submit Their Information Before August 4, 2026 Lead Plaintiff Deadline
exposures previously classified as Stage 2 to Stage 3, leading to an incremental ECL charge of R$88 million in the three months ended December 31, 2025; (iii) PicS N.V. had experienced a heightened, but unreported, Stage 3 formation rate of more than 7% in the fourth quarter of 2025 that deviated substantially
More news about: Johnson Fistel, PLLP
Jun 12, 2026, 09:00 ET "Be The People" Releases Song "Gotta Be Us (Be The People)," a New Anthem Inviting Americans to Show Up and Solve Problems in Their Communities
Atlanta Changemakers, a citywide initiative celebrating local leaders including National Leadership Council members Martin Luther King III and Arndrea Waters King for making a difference in their community. Hundreds of nominations were submitted, culminating in Atlanta educator Mikal Driver
More news about: Be The People
Jun 12, 2026, 09:00 ET Braeburn to Present Research at CPDD 2026 Annual Meeting, Including Data on Withdrawal Suppression and Real-World Treatment Retention in Patients With Opioid Use Disorder
solution for injection.WARNINGS AND PRECAUTIONSAddiction, Abuse, and Misuse: BRIXADI contains buprenorphine, a Schedule III controlled substance that can be abused in a manner similar to other opioids. Buprenorphine is sought by people with opioid use disorder and is subject
More news about: Braeburn